Abstract
L-Asparaginase is a chemotherapeutic agent against various types of cancer due to its asparagine depleting ability. Previously, we have characterized a highly active and thermostable L-Asparaginase (TK1656) from Thermococcus kodakarensis and reported its anti-cancerous effects against acute lymphoblastic leukemia. In the current study, we report anti-proliferative and cytotoxic effects of TK1656 on glioblastoma cell line SF767. Our results showed that TK1656 reduced the proliferation of glioblastoma cells after 72 h in a dose-dependent manner while leaving Vero cells unaffected. The IC50 of TK1656 against SF767 cells was calculated as 18 µg/mL by neutral red uptake assay. Phase-contrast microscopy showed pronounced morphological changes in TK1656 treated SF767 cells. Likewise, DAPI staining and DNA laddering showed that TK1656 has strong genotoxic effects on glioblastoma cells. The AO/EB dual staining pointed out the induction of apoptosis in TK1656 treated cells. Activation of Caspases 3, 6, and 8, after TK1656 treatment, further substantiated the notion of apoptosis mediated death in these cells. Furthermore, flow cytometry data showed that TK1656 treatment induced cell cycle arrest with an increased sub-G1 cell population and downregulation of CDK2 and CDK4. Altogether, our data revealed that TK1656 induces apoptosis and cell cycle arrest in glioblastoma cells. Our findings prompt further investigations to approve the use of TK1656 for the effective treatment of glioblastoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- GBM:
-
Glioblastoma multiforme
- TK1656:
-
Thermococcus kodakarensis derived 1656
- IC50 :
-
half maximal inhibitory concentration
- ASN:
-
Asparagine synthetase
- FBS:
-
Fetal bovine serum
- AO:
-
Acridine orange
- EB:
-
Ethidium bromide
- CDK2:
-
Cyclin dependent kinases 2
- CDK4:
-
Cyclin dependent kinases 4
- qRTPCR:
-
Quantitative real-time polymerase chain reaction
References
Abd HE, El GB (2020) Spirulina maxima L asparaginase: immobilization, antiviral and antiproliferation activities. Recent Pat Biotechnol 14. https://doi.org/10.2174/1872208313666191114151344
Alrumman SA, Mostafa YS, Al-Izran KA, Alfaifi MY, Taha TH, Elbehairi SE (2019) Production and anticancer activity of an l-asparaginase from Bacillus licheniformis isolated from the Red Sea, Saudi Arabia. Sci Rep 9:1–4. https://doi.org/10.1038/s41598-019-40512-x
Avramis IA, Christodoulopoulos G, Suzuki A, Laug WE, Gonzalez-Gomez I, McNamara G et al (2002) In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSCá680410 against human leukemia and glioblastoma cell lines. Cancer Chemoth Pharm 50:479–489. https://doi.org/10.1007/s00280-002-0507-6
Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T (2016) Potential of apoptotic pathway- targeted cancer therapeutic research: Where do we stand? Cell Death Dis 7:e2058. https://doi.org/10.1038/cddis.2015.275
Baskar G, Sree NS (2020) Synthesis, characterization and anticancer activity of β-cyclodextrin- Asparaginase nanobiocomposite on prostate and lymphoma cancer cells. J Drug Deliv Sci Tec 55:101417. https://doi.org/10.1016/j.jddst.2019.101417
Baskar G, Lalitha K, Garrick BG, Chamundeeswari M (2017) Conjugation, labeling and characterization of asparaginase bound silver nanoparticles for anticancer applications. Indian J Exp Biol 55:421–426
Batool T, Makky EA, Jalal M, Yusoff MM (2016) A comprehensive review on L-asparaginase and its applications. Appl Biochem Biotechnol 178:900–923. https://doi.org/10.1007/s12010-015-1917-3
Bonelli M, La Monica S, Fumarola C, Alfieri R (2019) Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation. Biochem Pharmacol 21:11367. https://doi.org/10.1016/j.bcp.2019.113676
Chen Q, Ye L, Fan J, Zhang X, Wang H, Liao S et al (2017) Autophagy suppression potentiates the anti- glioblastoma effect of asparaginase in vitro and in vivo. Oncotarget 8:91052. https://doi.org/10.18632/oncotarget.19409
Chiu M, Taurino G, Bianchi MG, Kilberg MS, Bussolati O (2019) Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia. Front Oncol 9. https://doi.org/10.3389/fonc.2019.01480
Chohan SM, Rashid N (2013) TK1656, a thermostable L-asparaginase from Thermococcus kodakaraensis, exhibiting highest ever reported enzyme activity. J Biosci Bioeng 116:438–443. https://doi.org/10.1016/j.jbiosc.2013.04.005
Chohan SM, Nisar MA, Rashid N, Gharib G, Bashir Q, Siddiqui MA (2016) TK1656, an L-asparaginase from Thermococcus kodakarensis, a novel candidate for therapeutic applications. Biologia 71:1315–1319. https://doi.org/10.1515/biolog-2016-0168
Chohan TA, Qayyum A, Rehman K, Tariq M, Akash MS (2018) An insight into the emerging role of cyclin- dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers. Biomed Pharmacother 107:1326–1341. https://doi.org/10.1016/j.biopha.2018.08.116
Chong QY, Kok ZH, Xiang X, Wong AL, Yong WP, Sethi G et al (2020) A unique CDK4/6 inhibitor: current and future therapeutic strategies of abemaciclib. Pharmacol Res 14:104686. https://doi.org/10.1016/j.phrs.2020.104686
Covini D, Tardito S, Bussolati O, R Chiarelli L, V Pasquetto M, Digilio R et al (2012) Expanding targets for a metabolic therapy of cancer: L-asparaginase. Recent Pat Anti-Cancer Drug Discov 1:4–13. https://doi.org/10.2174/157489212798358001
Dhankhar R, Gupta V, Kumar S, Kapoor RK, Gulati P (2020) Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment. Appl Microbiol Biotechnol 104:2857–2869. https://doi.org/10.1007/s00253-020-10432-2
Dolowy WC, Cornet J, Henson D, Ammeraal R (1966) Response of intracerebral Gardner lymphoma to guinea pig L-asparaginase and Escherichia coli L-asparaginase. Exp Biol Med 123:133–137. https://doi.org/10.3181/00379727-123-31422
Effer B, Lima GM, Cabarca S, Pessoa A, Farías JG, Monteiro G (2019) L- Asparaginase from E. chrysanthemi expressed in glycoswitch®: effect of His-Tag fusion on the extracellular expression. Prep Biochem Biotech 49:679–685. https://doi.org/10.1080/10826068.2019.1599396
Ford MJ (2017) Design and implementation of transgenic tools to visualise cell cycle progression in mammalian development. Dissertation. University of Edinburgh
Fung M, Chan GC (2017) Drug-induced amino acid deprivation as strategy for cancer therapy. J Hematol Oncol 10(1):144. https://doi.org/10.1186/s13045-017-0509-9
Hatoum A, Mohammed R, Zakieh O (2019) The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix. Cancer Manag Res 11:1843. https://doi.org/10.2147/cmar.s186142
Ishida F, Ko YH, Kim WS, Suzumiya J, Isobe Y, Oshimi K et al (2012) Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation. Cancer Sci 103:1079–1083. https://doi.org/10.1111/j.1349-7006.2012.02251.x
Karpel-Massler G, Ramani D, Shu C, Halatsch ME, Westhoff MA, Bruce JN et al (2016) Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo. Oncotarget 7:33512. https://doi.org/10.18632/oncotarget.9257
Kwan YP, Saito T, Ibrahim D, Al-Hassan FM, Ein Oon C, Chen Y et al (2016) Evaluation of the cytotoxicity, cell- cycle arrest, and apoptotic induction by Euphorbia hirta in MCF-7 breast cancer cells. Pharm biol 54:1223–1236. https://doi.org/10.3109/13880209.2015.1064451
Lane AN, Higashi RM, Fan TW (2019) Metabolic reprogramming in tumors: contributions of the tumor microenvironment. Genes Dis 7:185–198. https://doi.org/10.1016/j.gendis.2019.10.007
LeBoeuf SE, Wu WL, Karakousi TR, Karadal B, Jackson SR, Davidson SM et al (2020) Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids. Cell Metab 31:339–350. https://doi.org/10.1016/j.cmet.2019.11.012
Lisi L, Chiavari M, Ciotti GM, Lacal PM, Navarra P, Graziani G (2020) DNA inhibitors for the treatment of brain tumors. Expert Opin Drug Metab Toxicol 16:195–207. https://doi.org/10.1080/17425255.2020.1729352
Liu K, Liu PC, Liu R, Wu X (2015) Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med Sci Monit Basic Res 21:15. doi:https://doi.org/10.12659/MSMBR.893327
Lucero R, Zappulli V, Sammarco A, Murillo OD, Cheah PS, Srinivasan S et al (2020) Glioma-derived miRNA- containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells. Cell Rep 30:2065–2074. https://doi.org/10.1016/j.celrep.2020.01.073
Machana S, Weerapreeyakul N, Barusrux S, Thumanu K, Tanthanuch W (2012) Synergistic anticancer effect of the extracts from Polyalthia evecta caused apoptosis in human hepatoma (HepG2) cells. Asian Pac J Trop Biomed 2:589–596. https://doi.org/10.1016/s2221-1691(12)60103-8
Movahed ZG, Rastegari-Pouyani M, Hossein Mohammadi M, Mansouri K (2019) Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomed Pharmacother 112:108690. https://doi.org/10.1016/j.biopha.2019.108690
Ohba S, Hirose Y (2020) l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells. J Neuro-Oncol 146:469–475. https://doi.org/10.1007/s11060-019-03351-4
Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR et al (2014) Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res 12:694–702. https://doi.org/10.1158/1541-7786.mcr-13-0576
Petersen J (2019) Investigation into the anticancer mechanism of action of novel 4 substituted phenylthiazoles and antihelminthic benzimidazoles. Dissertation, University of Otago
Poreba M, Groborz K, Navarro M, Snipas SJ, Drag M, Salvesen GS (2019) Caspase selective reagents for diagnosing apoptotic mechanisms. Cell Death Differ 26:229–244. https://doi.org/10.1038/s41418-018-0110-y
Pozarowski P, Darzynkiewicz Z (2004) Analysis of cell cycle by flow cytometry. In: Checkpoint controls and cancer. Humana Press, Totowa, pp 301–311. https://doi.org/10.1385/1-59259-811-0:301
Priya Rani M, Padmakumari KP, Sankarikutty B, Lijo Cherian O, Nisha VM, Raghu KG (2011) Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr 62:106–110. https://doi.org/10.3109/09637486.2010.515565
Qeshmi FI, Homaei A, Fernandes P, Javadpour S (2018) Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry. Microbiol Res 208:99–112. https://doi.org/10.1016/j.micres.2018.01.011
Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458–1461. https://doi.org/10.1038/nprot.2006.238
Rodríguez-Enríquez S, Marín-Hernández Á, Gallardo-Pérez JC, Pacheco-Velázquez SC, Belmont-Díaz JA, Robledo-Cadena DX et al (2019) Transcriptional regulation of energy metabolism in cancer cells. Cells 8:1225. https://doi.org/10.3390/cells8101225
Roskoski R Jr (2019) Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Pharmacol Res 139:471–488. https://doi.org/10.1016/j.phrs.2018.11.035
Sanghez V, Chen M, Li S, Chou TF, Iacovino M, Lin HJ et al (2018) Efficacy of asparaginase Erwinia chrysanthemi with and without temozolomide against glioma cells and intracranial mouse medulloblastoma. Anticancer Res 38:2627–2634. https://doi.org/10.21873/anticanres.12504
Santa Maria A, Lopez A, Diaz MM, Munoz-Mingarro D, Pozuelo JM (1998) Evaluation of the toxicity of guarana within VitroBioassays. Ecotoxicol Environ Saf 39:164–167. https://doi.org/10.1006/eesa.1997.1576
Shiratori R, Furuichi K, Yamaguchi M, Miyazaki N, Aoki H, Chibana H et al (2019) Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci Rep 9:1–5. https://doi.org/10.1038/s41598-019-55296-3
Takahashi H, Inoue J, Sakaguchi K, Takagi M, Mizutani S, Inazawa J (2017) Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells. Oncogene 36:4267–4276. https://doi.org/10.1038/onc.2017.59
Venkatesh VS, Lou E (2019) Tunnelling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? Cancer Rep 2:e1185. https://doi.org/10.1002/cnr2.1185
Vettore L, Westbrook RL, Tennant DA (2019) New aspects of amino acid metabolism in cancer. Br J Cancer 10:1–7. https://doi.org/10.1038/s41416-019-0620-5
Vince JE, De Nardo D, Gao W, Vince AJ, Hall C, McArthur K et al (2018) The mitochondrial apoptotic effectors BAX/BAK activate caspase-3 and-7 to trigger NLRP3 inflammasome and caspase-8 driven IL-1β activation. Cell Rep 25:2339–2353. https://doi.org/10.1016/j.celrep.2018.10.103
Wang Y, Ma S, Ruzzo WL (2020) Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities. Sci Rep 10:1–4. https://doi.org/10.1101/719294
Yalonetskaya A, Mondragon AA, Hintze ZJ, Holmes S, McCall K (2020) Nuclear degradation dynamics in a nonapoptotic programmed cell death. Cell Death Differ 27:711–724. https://doi.org/10.1038/s41418-019-0382-x
Yoshida A, Bu Y, Qie S, Wrangle J, Camp ER, Hazard ES et al (2019) SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Sci Adv 5:eaax6352. https://doi.org/10.1126/sciadv.aax6352
Yun MK, Nourse A, White SW, Rock CO, Heath RJ (2007) Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I. J Mol Biol 369:794–811. https://doi.org/10.1016/j.jmb.2007.03.061
Acknowledgements
We are highly thankful to School of the Biological Sciences, University of the Punjab, Lahore, Pakistan to provide funding and research facilities to conduct this study.
Author information
Authors and Affiliations
Contributions
H.N and S.G contributed the experimental work. Q.B. helped in the study design and data analysis. N.S. wrote the manuscript and analyzed the data. N.R. purified the L-asparaginase TK1656 and proofread the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest among all the contributing authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Naz, H., Gull, S., Bashir, Q. et al. Thermococcus kodakarensis-derived L-asparaginase: a candidate for the treatment of glioblastoma. Biologia 76, 1305–1314 (2021). https://doi.org/10.2478/s11756-021-00678-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-021-00678-0